Candel Therapeutics (CADL) Current Leases (2022 - 2025)

Candel Therapeutics has disclosed Current Leases across 4 years of filings, most recently posting $445000.0 for Q4 2025.

• Current Leases for Q4 2025 came in at $445000.0, down 21.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $445000.0 (down 21.38% YoY), and the FY2025 annual result was $445000.0, down 21.38% from the prior year.
• Current Leases came in at $445000.0 for Q4 2025 at Candel Therapeutics, up from $437000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $594000.0 in Q2 2025 to a low of $429000.0 in Q1 2022.
• The 4-year median for Current Leases is $494000.0 (2023), against an average of $500062.5.
• Across the five-year window, Current Leases climbed 10.96% in 2023 and slipped 21.38% in 2025, its largest moves.
• Candel Therapeutics' Current Leases stood at $464000.0 in 2022, then climbed by 10.56% to $513000.0 in 2023, then increased by 10.33% to $566000.0 in 2024, then decreased by 21.38% to $445000.0 in 2025.
• The last three Current Leases figures came in at $445000.0 (Q4 2025), $437000.0 (Q3 2025), and $594000.0 (Q2 2025), per Business Quant data.